Anshi Shukla

Anshi Shukla is a seasoned scientist with extensive experience in biomedical research and a focus on immunology and nanotechnology. Currently serving as Scientist II and Flow Cytometry Lead at NexImmune, Inc. since May 2021, Anshi conceptualizes and designs experiments aimed at evaluating T cell products derived from Artificial Immune Modulation technology. Prior roles include Post-Doctoral Scientist at the George Washington University, where Anshi engineered multifunctional Prussian blue nanoparticles for cancer therapy, and Research Specialist II at MedStar Georgetown University Hospital, investigating immune responses in intestinal transplantation. Anshi's academic background includes a Ph.D. in Microbiology and Molecular Biology from Banaras Hindu University and several clinical research courses from prestigious institutions such as Johns Hopkins and the NIH.